by Marnet Team | Mar 5, 2026 | News, Business
Mirum Pharmaceuticals, Inc. posts full-year 2025 financial results and outlines key business updates and strategic priorities for 2026. Mirum Pharmaceuticals, Inc. a leading biopharmaceutical company focused on rare diseases, reported strong fourth quarter and...
by Marnet Team | Mar 5, 2026 | News
Swiss neurotech spin-off accelerates development of ultra-high-resolution intraoperative imaging to enhance precision and safety in brain surgery. The Wyss Center for Bio and Neuroengineering has announced the successful closing of the Seed financing round for Clee...
by Marnet Team | Mar 5, 2026 | Regulatory, News
SystImmune and Bristol Myers Squibb announce interim Phase III data showing Iza-bren significantly improves outcomes in previously treated triple-negative breast cancer (TNBC) patients. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results...
by Marnet Team | Mar 5, 2026 | News
The agreement grants worldwide rights to two clinical-stage NSCLC therapies, expanding Kairos Pharma’s oncology pipeline through a strategic asset acquisition from Celyn Therapeutics. Kairos Pharma, Ltd. has announced the signing of a term sheet to acquire two...
by Marnet Team | Mar 5, 2026 | News
The U.S. Food and Drug Administration Accepts Supplemental NDA for Accelerated Evaluation, Setting a PDUFA Target Action Date of June 30, 2026 Ionis Pharmaceuticals, Inc. has announced a significant regulatory milestone for its investigational therapy olezarsen, as...
by Marnet Team | Mar 5, 2026 | Regulatory, News
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based gene editing platform as a potential therapeutic approach for Rett syndrome. Evox Therapeutics Ltd has announced the launch of a new strategic collaboration...
by Marnet Team | Mar 5, 2026 | Technology, News
New findings reinforce the clinical value of Aventa Lymphoma test for detecting diagnostically and therapeutically relevant genomic rearrangements in routine pathology samples. Arima Genomics, Inc., a precision oncology company harnessing whole-genome sequence and...
by Marnet Team | Mar 5, 2026 | Regulatory, News
New clinical study results highlight significant reductions in residual stone volume and follow-up health complications with Calyxo’s CVAC System. Calyxo, Inc., a medical device innovator transforming the treatment of kidney stones, has announced the peer-reviewed...
by Marnet Team | Mar 5, 2026 | News
ENDRA Life Sciences Demonstrates High Consistency in TAEUS® Liver Device for MASLD Monitoring ENDRA Life Sciences Inc , a leading innovator in thermoacoustic imaging technology, has reported highly favorable results from a recent clinical study evaluating the...
by Marnet Team | Mar 5, 2026 | News, Press Releases
Sierra Space Appoints Dan Jablonsky as Chief Executive Officer to Drive Next Phase of Growth Across National Security and Space Markets Sierra Space, a leading aerospace and defense technology company recognized for delivering critical solutions to the nation’s most...
